Mouse IFN-γ T cell ELISPOT kit - 5-plate

SKU
CT317-B5
Complete ELISPOT kit including all reagents (480 determinations).
Format
5-plate
Price
€ 670
Documentation
Data sheet
Manual
SDS
Reactivity
Mouse
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assay. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, and Tween-20.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
15978
Related Products
CT317-B2 - Mouse IFN-γ T cell ELISPOT kit - 2-plate

References

Authors, et al. Title Journal Year Volume Pages
Huadong Wang Complete protection of mice against lethal murine cytomegalovirus challenge by immunization with DNA vaccines encoding envelope glycoprotein complex III antigens gH, gL and gO PLoS One 2015 10 e0119964
S Huber Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets PLoS One 2015 10 e0127969
Zenglin Pei Oral Delivery of a Novel Attenuated Salmonella Vaccine Expressing Influenza A Virus Proteins Protects Mice against H5N1 and H1N1 Viral Infection PLoS One 2015 10 e0129276
Sheida Shariat P5 HER2/neu-derived peptide conjugated to liposomes containing MPL adjuvant as an effective prophylactic vaccine formulation for breast cancer Cancer Lett 2014 355 54-60
Biao He Infection of influenza virus neuraminidase-vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses J Gen Virol 2014 95 2627-2637
Mercedeh Mansourian Effective induction of anti-tumor immunity using p5 HER-2/neu derived peptide encapsulated in fusogenic DOTAP cationic liposomes co-administrated with CpG-ODN Immunol Lett 2014 162 87-93
Marije Baas Combining autologous dendritic cell therapy with CD3 antibodies promotes regulatory T cells and permanent islet allograft acceptance J Immunol 2014 193 4696-703
Ying Xu Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice Immunology 2014 143 277-86
Y Fuchs IGRP and insulin vaccination induce CD8+ T cell-mediated autoimmune diabetes in the RIP-CD80GP mouse Clin Exp Immunol 2014 176 199-206
Alicja Chmielewska Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses J Virol 2014 88 5502-10